Physician profile
Stephen M Chan
NPI 1235333741
$2,032.07
in general payments reported to CMS, 2019-2025
11 companies · $69.37 in 2025
The $69.37 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $68.80 · 2021: $26.94 · 2022: $103 · 2023: $143 · 2024: $328 · 2025: $69.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301 · Education: $200 · Gift: $38.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.47 |
| Education | $200.00 |
| Gift | $38.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,120.61 | 2019-2020 | |
| Straumann USA LLC | $398.01 | 2023-2025 | |
| Ace Surgical Supply Co., INC. | $155.27 | 2019-2020 | |
| Biohorizons Implant Systems INC. | $96.07 | 2019-2023 | Biohorizons |
| Zimvie INC. | $89.12 | 2022-2024 | |
| Dentsply Sirona INC | $45.26 | 2024 | Primescan Connect |
| Smith+Nephew, INC. | $43.13 | 2019 | |
| Keystone Dental INC. | $26.40 | 2019 | |
| Geistlich Pharma, North America, INC. | $26.04 | 2024 | Geistlich Bio-Gide |
| Acelrx Pharmaceuticals, INC. | $17.12 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.04 | 2023 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.